M&A Deal Summary |
|
|---|---|
| Date | 2024-12-18 |
| Target | VitaSmart |
| Sector | Medical Products |
| Buyer(s) | Bridge to Life |
| Sellers(s) | Medica |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Bridge to Life develops and provides advanced preservation solutions and technologies for organ procurement organizations and transplant centers. Bridge to Life is based in London, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Medical Products) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| Country (United Kingdom) | 1 of 1 |
| Year (2024) | 1 of 1 |
Medica provides hollow fiber membrane filtration technology for medical device applications and water purification. The company's hollow fiber membrane filtration products are used for blood purification in numerous applications including dialysis, continuous renal replacement therapies (CRRT), and therapeutic apheresis. Medica was formed in 1985 and is based in Medolla, Italy.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Medical Products) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| Country (United Kingdom) | 1 of 1 |
| Year (2024) | 1 of 1 |
